TD Cowen Reiterates Buy on CME Group, Maintains $292 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.3%

Neg 0% Neu 87.3% Pos 0%

TD Cowen analyst Bill Katz reiterates CME Group (NASDAQ:CME) with a Buy and maintains $292 price target.

Comments

No comments yet. Be the first!